688488 Jiangsu Aidea Pharmaceutical
- 9.69
- +0.30+3.19%
Jiangsu Aidea Pharmaceutical News
Eddy Pharmaceutical\'s announcement on the completion of the plan for directors and senior management to reduce shareholding through centralized bidding and share holdings reduction results
Eddy Pharmaceuticals: Eddy Pharmaceuticals Announcement on Pledging Shares in Holding Subsidiaries
Eddy Pharmaceutical\'s announcement on the plan for the company\'s directors and senior management to reduce their shareholding through centralized bidding
Jiangsu Aidea Pharmaceutical's announcement on the issuance of A shares to specific investors does not involve providing financial assistance or compensation to investors who participate in the subscription directly or through related parties.
Announcement of Jiangsu Aidea Pharmaceutical on the dilution of immediate returns and the adoption of remedial measures and related party commitments in the issuance of A shares to specific entities.
Jiangsu Aidea Pharmaceutical's announcement on requesting the shareholders' general meeting to approve the subscription object and the exemption of the concerted actors from increasing the shareholding of the company's shares by way of tender offer.
Jiangsu Aidea Pharmaceutical plans to issue A-share stocks to specific entities in 2024.
Jiangsu Aidea Pharmaceutical's analysis report on the plan for the issuance of A shares to specific objects in 2024
jiangsu aidea pharmaceutical's shareholder dividend return plan for the next three years (2024-2026).
Feasibility Analysis Report on the Use of Raised Funds for the Issuance of A Shares by Jiangsu Aidea Pharmaceutical in 2024 to Specific Objects
Jiangsu Aidea Pharmaceutical's indicative announcement regarding the issuance of A-shares to specific entities.
Announcement on the Progress of Shareholding by Actual Controller and President of Jiangsu Aidea Pharmaceutical
Announcement Regarding the Shareholding Plan of the Actual Controller and President of Jiangsu Aidea Pharmaceutical
Eddy Pharmaceutical's announcement on the completion of the actual controller's plan to increase shareholding and the results of the increase in holdings
Eddy Pharmaceuticals's indicative announcement on planning major asset restructuring and signing the “Intent to Acquire Share Agreement”
Eddy Pharmaceutical\'s announcement on the progress of the actual controller\'s increase in shareholding
Eddy Pharmaceutical\'s announcement on the actual controller\'s plan to increase its shareholding
EDI Pharmaceutical\'s announcement on granting reserve of some restricted shares to incentive recipients of the 2023 Restricted Stock Incentive Plan
Jiangsu Century Tongren Law Firm\'s legal opinion on the grant of some reservations for the 2023 Restricted Stock Incentive Plan of Jiangsu Eddy Pharmaceutical Co., Ltd.
List of incentive recipients reserved for Eddy Pharmaceutical\'s 2023 Restricted Stock Incentive Plan (as of grant date)
Analysis
Price Target
No Data
No Data